Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter

To determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support. DATA SOURCES: The first two patients in the United States treated with the novel Sera...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Crit Care Explor
Main Authors: Olson, Stephen W., Oliver, James D., Collen, Jacob, Bunin, Jessica, Gleeson, Todd D., Foster, Brian E., Simmons, Mark P., Chen, Hua W., Ficke, Jennifer B., Brown, Tara E., Nau, Mark T., Cebula, Brennan R., Kielstein, Jan, Chung, Kevin K.
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2020
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396271/
https://ncbi.nlm.nih.gov/pubmed/32766569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCE.0000000000000180
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki